Finance

Lists
Why is W5L down 98,89%?
Dive Deeper
W5L:FRA
Chosa Oncology AB
0,00020 €
-98,89%
(-0,018) 1D
9 қаз., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for W5L...
Open
0,01 €
High
0,01 €
Low
0,00 €
Volume
0,00
52-wk high
0,12 €
52-wk low
0,00 €
No. of employees
2
Open
0,01 €
High
0,01 €
Low
0,00 €
Volume
0,00
52-wk high
0,12 €
52-wk low
0,00 €
No. of employees
2
News stories
From web sources and news partners
About Chosa Oncology AB
CEO-
Employees2
Founded2007
Headquarters-
Sector-
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-3,93 млн
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,48 млн
4,07 млн
1,96 млн
2,84 млн
Operating expense
2,49 млн
794,00 м.
1,96 млн
2,84 млн
Total operating expenses
2,49 млн
794,00 м.
1,96 млн
2,84 млн
Operating income
-2,49 млн
-4,72 млн
-1,96 млн
-2,84 млн
Other non operating income
-52,00 мың
-8,75 мың
-2,00 мың
1,00 мың
EBT including unusual items
-2,54 млн
-4,92 млн
-1,87 млн
-2,63 млн
EBT excluding unusual items
-2,54 млн
-4,92 млн
-1,87 млн
-2,63 млн
Income tax expense
-
-1,01 млн
-
-
Effective tax rate
-
20,60%
-
-
Other operating expenses
5,00 мың
-3,93 млн
-2,00 мың
1,00 мың
Net income
-2,54 млн
-3,91 млн
-1,87 млн
-2,63 млн
Net profit margin
-
99,41%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
310,20 м.
95,00 мың
248,00 м.
Interest expense
-
-116,05 м.
-2,00 мың
-43,00 мың
Net interest expenses
-
194,16 м.
93,00 мың
205,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,46 млн
-4,08 млн
-1,78 млн
-2,66 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары